BioSpace News Archive

Four studies being presented during the 62nd American Society of Hematology Annual Meeting and Exposition highlight the ways disparities and inequities affect the health threats faced by people in racial and ethnic minorities, as well as the quality of health care they receive.

The Janssen Pharmaceutical Companies of Johnson & Johnson announced results of the Phase 3 APOLLO study showing that the addition of DARZALEX FASPRO ®

Incyte Announces First Data from REACH3 Trial Showing Ruxolitinib (Jakafi ® ) Significantly Improved Outcomes in Patients with Steroid-Refractory or Steroid-Dependent Chronic Graft-Versus-Host Disease - Results of REACH3 trial also demonstrate significant improvements in failure-free survival (FFS) and patient-reported symptoms 1 - Findings from the study are being presented at ASH 2020, and complement previously-reported positive results for Jakafi in

KU Leuven, a leading research institution and one of the top 50 universities in the world and Batavia Biosciences, a contract development and manufacturing organization focused on delivering sustainable manufacturing solutions in the field of vaccines and oncology, today announce their partnership on the development of a vector based COVID-19 vaccine candidate.

Four studies being presented during the 62nd American Society of Hematology (ASH) Annual Meeting and Exposition present opportunities to improve care for patients with a variety of blood disorders. Together, the studies provide supp

While multiple research studies show that Black and Hispanic patients are more likely to test positive for COVID-19, a team of investigators at NYU Langone Health has found that once hospitalized, Black patients (after controlling for other serious health conditions and neighborhood income) were less likely to have severe illness, die, or be discharged to hospice compared to White patients.

Ensemble Orthopedics Inc. today announced that it has received 510(k) clearance from the U.S. Food and Drug Administration for its Ensemble CMC Implant.

Solidarity HealthShare (SHS), a non-profit, affordable, ethical healthcare sharing ministry alternative to traditional health insurance has partnered with Cancer Treatment Centers of America® (CTCA) to provide its members access to world-class affordable cancer care.

Vizient, Inc. submitted comments to the Food and Drug Administration (FDA) today applauding the agency’s efforts to publish a list of essential medicines, medical countermeasures and critical inputs to help prepare for the next potential public health emergency

Intellia Therapeutics, Inc. (NASDAQ:NTLA), a leading genome editing company focused on developing curative therapeutics using CRISPR/Cas9 technology both in vivo and ex vivo, announced today the closing of an underwritten public offering of 5,513,699 shares of its common stock, including the exercise in full by the underwriters of their option to purchase an additional 719,178 shares,